- Home
- DNLI vs QLYS Comparison
DNLI vs QLYS Comparison
Compare DNLI & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | QLYS |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 2017 | 2012 |
Fundamental Metrics
Financial Performance| Metric | DNLI | QLYS |
|---|---|---|
| Price | $23.02 | $144.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 13 |
| Target Price | $34.33 | ★ $133.08 |
| AVG Volume (30 Days) | ★ 1.7M | 728.1K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.99 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $321,607,000.00 |
| Revenue This Year | N/A | $9.97 |
| Revenue Next Year | $408.85 | $7.15 |
| P/E Ratio | ★ N/A | $99.56 |
| Revenue Growth | N/A | ★ 15.32 |
| 52 Week Low | $12.58 | $74.51 |
| 52 Week High | $27.30 | $167.86 |
Technical Indicators
Market Signals| Indicator | DNLI | QLYS |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 53.84 |
| Support Level | $18.27 | $125.65 |
| Resistance Level | $27.30 | $154.54 |
| Average True Range (ATR) | 1.20 | 8.56 |
| MACD | -0.15 | -2.73 |
| Stochastic Oscillator | 29.20 | 32.34 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.